Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2026-01-01 @ 5:46 AM
Study NCT ID:
NCT04906434
Status:
RECRUITING
Last Update Posted:
2025-11-12
First Post:
2021-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
Sponsor:
Abbisko Therapeutics Co, Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-21
First Submit QC Date:
None
Study First Post Date:
2021-05-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-10
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED